financetom
Business
financetom
/
Business
/
Investment Guide: What will drive consumption in the post-COVID era?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investment Guide: What will drive consumption in the post-COVID era?
Oct 21, 2020 9:44 AM

As the economy goes through various stages of unlock, and everyone tries to limb back to some semblance of normalcy, the big question is are people going to open up their purse strings. And if they are, what will they spend on.

Nikhil Vora, Founder & CEO of Sixth Sense Ventures said that pandemic has cut short the time in which certain changes were to happen.

“A lot of times there has to be something drastic that happens and changes the way businesses operate and that event basically cuts short the time period which is required for the change to happen. COVID in India is possibly one such moment,” he said.

According to Vora, brand loyalty in India is at an all-time low and brand awareness is at an all-time high.

“This is a great case for disruption to happen. So, unlike in the past, now new-age brands, both on the physical side as also on the B2C side, have an ability to take 2-10 percent market share which possibly they would have taken over a 5-7 year period if they survived, to now possibly taking that sort of market share in a 3 year period,” he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Richtech Prices $21 Million Public Offering of Stock, Warrants
Richtech Prices $21 Million Public Offering of Stock, Warrants
Sep 1, 2024
04:00 AM EDT, 08/30/2024 (MT Newswires) -- Richtech Robotics ( RR ) said late Thursday it has priced an upsized public offering of about 15.6 million shares of its class B common stock and warrants to purchase up to about 15.6 million class B common shares at a combined price of $1.35 per share and accompanying warrant for total expected...
PennyMac Financial Services Insider Sold Shares Worth $1,024,200, According to a Recent SEC Filing
PennyMac Financial Services Insider Sold Shares Worth $1,024,200, According to a Recent SEC Filing
Sep 1, 2024
03:33 AM EDT, 08/30/2024 (MT Newswires) -- James K Hunt, Director, on August 27, 2024, sold 10,000 shares in PennyMac Financial Services ( PFSI ) for $1,024,200. Following the Form 4 filing with the SEC, Hunt has control over a total of 58,643 shares of the company, with 31,822 shares held directly and 26,821 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745916/000112760224023191/xslF345X05/form4.xml Price:...
CommVault Systems Insider Sold Shares Worth $2,621,367, According to a Recent SEC Filing
CommVault Systems Insider Sold Shares Worth $2,621,367, According to a Recent SEC Filing
Sep 1, 2024
03:35 AM EDT, 08/30/2024 (MT Newswires) -- Gary Merrill, Chief Commercial Officer, on August 27, 2024, sold 17,388 shares in CommVault Systems ( CVLT ) for $2,621,367. Following the Form 4 filing with the SEC, Merrill has control over a total of 94,530 shares of the company, with 94,530 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1169561/000116956124000111/xslF345X05/wk-form4_1724970569.xml Price: 152.70, Change: +0.08, Percent...
Hutchmed Withdraws China Application for Gastric Cancer Drug
Hutchmed Withdraws China Application for Gastric Cancer Drug
Sep 1, 2024
03:55 AM EDT, 08/30/2024 (MT Newswires) -- Hutchmed ( HCM ) said Friday it has withdrawn its supplemental new drug application in China for fruquintinib in combination with paclitaxel for the potential treatment of second-line advanced gastric or gastroesophageal junction adenocarcinoma. Hutchmed ( HCM ) said a review of data and consultations with regulators suggested that the treatment is unlikely...
Copyright 2023-2026 - www.financetom.com All Rights Reserved